Molecular Diagnostics Devices And Equipment Market Size Projected To Reach $24.77 Billion By 2034 With A Cagr Of 6.8%

The Molecular Diagnostics Devices And Equipment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Molecular Diagnostics Devices And Equipment Market?
The market for molecular diagnostics devices and equipment has seen a significant surge in recent years. The market size, which stood at $17.58 billion in 2024, is projected to escalate to $19.01 billion in 2025, marking a compound annual growth rate (CAGR) of 8.1%. Factors contributing to the historic expansion include increased funding, growth in healthcare spending, economic development in emerging markets, swift advancements in technology, the emergence of new pathogenic infestations, and the growing elderly population.

The market for molecular diagnostics devices and equipment is projected to experience robust growth in the upcoming years. It is forecasted to reach $24.77 billion by 2029, expanding at a compound annual growth rate (CAGR) of 6.8%. The escalation predicted for the forecast period is linked to the swift increase in various bacterial and viral outbreaks, an aging population, advanced healthcare accessibility, heightened occurrence of chronic diseases, and the surge in demand for molecular diagnostic devices and equipment due to the COVID-19 pandemic. Key trends predicted for this period include the automation of molecular diagnostics, the incorporation of artificial intelligence, an uptick in the requirement for molecular diagnostic devices for studying rare conditions, the burgeoning adoption of big data, next generation sequencing for newborn screening, and the rise of point-of-care molecular diagnostics (POC mdx).

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2595

What Are the Different Molecular Diagnostics Devices And Equipment Market Segments?
The molecular diagnostics devices and equipment market covered in this report is segmented -

1) By Product: Instruments, Reagents And Consumables, Software
2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies
3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications
4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:
1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays
2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials
3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp

What Are the Primary Drivers Shaping the Molecular Diagnostics Devices And Equipment Market?
The growth of the molecular diagnostic devices and equipment market is forecasted to be pushed forward by the escalating prevalence of infectious illnesses. These infectious diseases are instigated by damaging microbes including bacteria, viruses, fungi, or parasites, and can be spread from person to person or from animals to people. Factors such as antimicrobial resistance, globalization and tourism, urban expansion, socioeconomic disparities, and a higher proportion of an older population are contributing to the increase in these diseases. Molecular diagnostic devices and equipment play a crucial role in identifying and managing infectious diseases. As an illustration, the UK government's Office for National Statistics revealed that in March 2023, during the week ending on March 17, 619 deaths caused by COVID-19 were documented, an increase from 605 on the previous week. Within this week, COVID-19 caused deaths made up 4.5% of all deaths in the UK, slightly lowering from a previous rate of 4.6%. Hence, the escalation in infectious diseases is fuelling the expansion of the molecular diagnostic devices and equipment market.

Which Companies Are Leading in the Molecular Diagnostics Devices And Equipment Market?
Major companies operating in the molecular diagnostics devices and equipment market include F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton inson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di'an Diagnostics Technology Co. Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, BGI-Shenzhen, OriGene Technologies, Bayer AG, Johnson & Johnson, Nippon Becton inson Company, QuantuMDx, Yourgene Health, Genefirst, Interlabservis, GeneMe, TestLine, Clinical Diagnostics s.r.o, Hologic Inc., Illumina Inc., Novartis AG, Cepheid Inc., Admera Health, Agilent technologies Inc., AutoGenomics, Bio-Red Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd.

What Trends Are Expected to Dominate the Molecular Diagnostics Devices And Equipment Market in the Next 5 Years?
Key figures in the molecular diagnostic market are concentrating on creating automated solutions for the appliances and machinery used in molecular diagnostic procedures. This automation can improve the effectiveness and uniformity of the entire diagnostic procedure. Digitizing the diagnostic procedure provides more reliable and efficient results than manual testing by various professionals. These main market actors are utilizing nanotechnology-based Oral Fluid Nano Sensor Tests (OFNASET). This test utilizes a nanosensor based on microfluidics to detect oral cancer biomarkers in saliva. In alignment with the trends of automation and precision, Roche has developed cobas connection modules (CCM) to bolster scalability and increase efficiency in sample flow by facilitating the automatic transfer of samples among various systems and instruments. In doing so, they have created a completely automated workflow.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

What Are the Top Revenue-Generating Geographies in the Molecular Diagnostics Devices And Equipment Market?
Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2024. Western Europe was the second largest market in molecular diagnostics devices (or) equipment market. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Molecular Diagnostics Devices And Equipment Market?
2. What is the CAGR expected in the Molecular Diagnostics Devices And Equipment Market?
3. What Are the Key Innovations Transforming the Molecular Diagnostics Devices And Equipment Industry?
4. Which Region Is Leading the Molecular Diagnostics Devices And Equipment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.